For over three decades, a highly accurate early diagnostic test for ovarian cancer has eluded physicians. Now, scientists in the Georgia Tech Integrated Cancer Research Center (ICRC) have combined ...
The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws LOS ANGELES--(BUSINESS WIRE)--Researchers at ...
A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled “SAMP ...
A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and ...
Modern cancer detection often depends on spotting tiny abnormalities in scans, something even trained specialists can miss.
The tool SAMP-Score has already screened 10,000 compounds and found one that safely forces stubborn, treatment-resistant cancers into permanent retirement.
A new research paper featured on the cover of Volume 17, Issue 11 of Aging-US was published on October 30, 2025, titled "SAMP ...
DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced that researchers from NYU Langone Health, in ...
A recent review article published in the journal Electronics comprehensively explored the transformative role of machine learning (ML) in cancer imaging, specifically focusing on diagnostic methods ...
Proven through research, driven by innovation, and tailor-made for those seeking to lead in breast health, ScreenPoint's Transpara (R) Breast AI is trusted by radiologists and women across the globe.